Health 10x Accelerator
Australia’s leading health and medtech accelerator, providing $100k in backing and support to scale globally.
Health 10x, built with The George Institute for Global Health, invests $100k in ambitious startups solving the world's most pressing unmet health and medical needs.
Health 10x, built in partnership with UNSW Founders and The George Institute for Global Health.
Since 2019, we've invested into 40 startups and supported 250+ health innovators from across Australia, including companies now expanding globally.
$100k to start. Incubation space, global landing pads and investor connections to keep going.
Applications for 2026 have closed.
Three things no other Australian health accelerator offers.
We back you with $100k, focus on the world's most challenging health problems, and open doors to global markets.
Here's how.
Now operating from Australia's most advanced health innovation precinct.
Health 10x operates from the Health Translation Hub — a $600M flagship facility opened in 2025, built to fast-track innovative health innovations from bench to bedside.
Nestled in the Randwick Health Innovation Precinct, we're steps from UNSW labs, Prince of Wales Hospital and integrated acute services.
Founders are plugged directly into clinicians, researchers and the ecosystem that turns ideas into real-world impact — not just told to go find them.
WHAT YOU GET
Built to get you funded, validated and global.
Built for health innovators who are brilliant at the science and ready to build the company around it. Navigating health commercialisation — regulatory, clinical, capital, global — is complex. We've built the program so you don't have to figure it out alone.
OUR ECOSYSTEM
The Infrastructure Behind You
Eight world-class partners: from global pharma to cutting-edge labs, embedded directly into supports at your fingertips. Flip each tile to see what they bring to your journey.
Meet The Founders Leading Women’s Health & Fertility Advancements
Catherine Slogrove from Amelia Bio
-
Catherine’s journey is deeply personal—after facing her own health challenges, she realised how the importance of vaginal health is overlooked. Frustrated by the lack of effective, accessible solutions, she became determined to create a product that empowers women to take control of their health.
Amelia Bio is her answer to a problem she once faced herself, driven by a mission to change the way we support and talk about women’s reproductive wellness.
Dr StevenVasilescu from NeoGenix
-
As a biomedical engineer with a PhD in fluid systems, Steven discovered how current fertility practices often fall short. His passion stems from the realisation that male infertility is under-diagnosed yet deeply impactful in family planning. Combining his technical expertise with a personal drive to improve reproductive medicine, he is committed to reshaping fertility care with hardware and AI-driven technologies.
Mark Grosser from 23Strands
-
Mark's work is deeply personal—his interest in genomics was sparked by his own family’s experience with health challenges that could have benefited from genetic insights. Frustrated by the one-size-fits-all approach in fertility care, he co-founded 23Strands to give patients data-backed, individualised solutions. His mission is to empower families with knowledge, ensuring that fertility treatments are as precise and effective as possible.
Ellen Gonda from GonGlobal
-
Ellen’s passion for innovation in reproductive health is rooted in her own IVF journey. Confronting the physical and emotional toll of fertility treatments firsthand, she saw an urgent need for better, less invasive solutions.
With GonGlobal, she is pioneering a new approach to IVF drug delivery—one that minimises discomfort and maximises accessibility. Her mission is clear: to revolutionise fertility care and ensure women have access to groundbreaking advancements that make the process easier and more effective.
Tori Fox from
Arelis
-
Tori’s innovative use of non-invasive urine test uses infrared spectroscopy and AI to deliver fast, accurate risk results, cutting diagnostic delays from years to weeks. Built for clinical impact, accessibility, and scale, Arelis gives providers a powerful new tool to diagnose sooner and treat faster. We're closing a critical gap in care and setting a new standard for how underdiagnosed conditions are identified and managed.
Essentials
Key Dates for Health 10× 2026
Applications open: 30 March
Applications close: 18 May
Bootcamp: 29-30 July
Program commences: 5 August
Program concludes: 7 October
Demo Day: 15 October
Suitable Applicants & The Right Fit
Who is this for?
You have a desire and vision to solve a global unmet health need
You are building a healthtech or medtech startup
You’re looking for the right support to help you accelerate company growth & drive your mission
We’re especially great at supporting:
All things health technology: from AI-ML innovations to medical technology devices
Academics and researchers who have a proof-of-concept and are looking to spin out
Technical/research teams requiring support and guidance around business and commercialisation
We help startups that:
Have an incorporated entity within Australia
Have rights to commercialise intellectual property
Have at minimum a proof of concept
Can commit to approximately 12 hours per week during the 10 week Accelerator phase
Have market validation through customer take-up or engagement
By submitting an application, you acknowledge and agree that all program selection decisions are final and not subject to review, appeal or challenge. Participation is subject to the UNSW Founders Terms & Conditions.
Want help with your health innovation right now?
Whether you're just starting out or deep in commercialisation - connect with our coaches and community today.
Meet a few of our Startups
Dr Peter Ayre, CardioLife
-
CardioLife (2019 alumni, formerly CardioBionic) is a pioneering medtech company dedicated to transforming heart failure treatment.
Their vision is to create a single, advanced control system platform for multiple cardiac support devices. This includes their VAS, an integrated digital control system managing ventricular assist devices (VADs) and cardiac catheters.
Their VADs, implantable pumps, offer vital support to compromised heart function, while the Cath, designed for acute heart failure, seamlessly integrates with the VAS for comprehensive care. CardioLife's innovative approach promises improved outcomes and renewed hope for heart failure patients worldwide.
Dr Louise Metcalfe, Gheorg
-
Gheorg, (2023 alumni) is a healthtech company enhancing children's emotional intelligence and mental well-being through their innovative robot companion.
With a vision to empower children to cultivate resilience and effectively manage stress, Gheorg utilises cutting-edge technology to provide personalised support and guidance.
Their friendly robot, designed to engage and connect with children, serves as a valuable tool in fostering emotional growth and equipping young individuals with essential skills for navigating life's challenges.
Diana Zhang, Preview Health
Guy Tsafnat, Evidentli
-
Evidentli (2019 alumni) is a dynamic medtech company revolutionising healthcare data management with their innovative platform.
Their cutting-edge technology swiftly standardises complex healthcare data and text with over 99% reliability in a matter of days, not months, and weeks, not years. By simplifying and unifying disparate clinical data, Evidentli empowers healthcare communities worldwide to advance patient care and outcomes.
With Evidentli, healthcare professionals can entrust their data management needs, allowing them to focus on delivering exceptional care and driving meaningful progress in healthcare.
David, Amit &
Ryan, VueMotion
-
VueMotion (2024 alumni) is a powerful tool for measuring human movement in athletic performance, walking quality, injury prevention and rehabilitation. Their core technology understands human movement in context, without any reliance on devices or sensors – just using smartphone video. VueMotion’s cutting-edge AI, Computer Vision and Cloud technologies have been refined over millions of frames of video and thousands of athletes, guided by world-leading experts across sport, health and technology.
Their platform is now used by over 1,000 organisations and coaches across the world, from professional to grass-roots clubs. It is currently the only Computer Vision AI/ML solution that is being used across all major sporting codes globally.
-
Preview Health (2024 alumni) is a pioneering medtech company dedicated to transforming the diagnosis of Parkinson's disease through advanced artificial intelligence (AI).
Their mission is to enable earlier and more accurate detection of Parkinson's, facilitating timely and personalised interventions to improve patient outcomes.
By leveraging AI-powered technology, Preview Health aims to revolutionise the diagnostic industry, starting with Parkinson's disease. Their innovative approach addresses the challenges of delayed and costly diagnoses by offering a streamlined process that enhances clinical confidence and reduces misdiagnosis.
Through their commitment to innovation and patient-centred care, Preview Health is poised to make a significant impact on the early detection and management of Parkinson's disease.
Read all about us in the news
